Historic: Here's why CSL shares are looking very interesting right now

CSL's yield now rivals a big four bank…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

As anyone who owns CSL Ltd (ASX: CSL) shares would be painfully aware, it has been a brutal few weeks to own this ASX 200 healthcare stock, and former market darling.

Back on 11 May, CSL lost almost 16% of its value in one session after reporting that it is expecting even lower revenues and profits than it had previously flagged for FY2026.

Investors responded by giving the company its worst one-day session in history. Of course, CSL was already on the nose with investors. Far from its halcyon days of over $340 a share in early 2020, the company lost more than half of its valuation between August 2025 and May 2026. And that was before that one-day car crash.

This has been devastating for many CSL investors, especially for those who have held on for years. The company today is at a price it first reached more than ten years ago. And it's not like CSL has paid out a lot in dividends over that time to make up for the loss of shareholder capital.

But now we are on the subject of dividends, let's dive in a little deeper, for something very interesting is happening on the CSL income front.

A woman with bright yellow hair wearing a brightly patterned blouse reacts to big news that she's reading on her phone.

Image source: Getty Images

What's happening with the dividend on CSL shares?

As any good dividend investor knows, a company's dividend yield is the function of two metrics. The first is the raw dividends per share that a company declares and pays out. But that alone doesn't determine a company's dividend yield. It is also influenced by its share price. A company can increase its dividends every single year. Yet if its share price rises at an even faster rate, its running yield will fall. The opposite is also true, though, which brings us to CSL.

On the first factor, CSL remains a winner. The company has been growing its annual payouts for more than a decade. Its final dividend last year was the largest it has ever funded (in US dollar terms), coming in at US$1.62 per share. The interim dividend that investors bagged last month was tied for its largest interim payout, matching last year's US$1.30 per share.

If we combine this with the fact that CSL shares are at a ten-year low, it may come as no surprise to see that its yield is currently at a record high. For much of CSL's recent history, investors would be lucky to see the company trade on a yield above 1%. Today, it is sitting at 3.08% (at the time of writing), ahead of Commonwealth Bank of Australia (ASX: CBA), if you can believe it.

Of course, just because CSL is trading with an historically high dividend yield doesn't mean it's a screaming buy. If CSL's profits are sagging, the company might be forced to cut its payouts next year. This, as we've already discussed, would naturally bring the company's yield back down. Even so, it's a very interesting development to see this company hit a 3% dividend yield. Let's see what happens next.

Motley Fool contributor Sebastian Bowen has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

4DMedical shares jump 11% as investors cheer major US agreement

4DMedical has landed another commercial foothold in the US.

Read more »

A man and woman sit next to each other looking at each other and feeling excited and surprised after reading good news about their shares on a laptop.
Healthcare Shares

Which ASX healthcare stock could rise over 100% according to Bell Potter?

Let's see what the broker is saying about this stock this week.

Read more »

Research, collaboration and doctors working digital tablet, analysis and discussion of innovation cancer treatment. Healthcare, teamwork and planning by experts sharing idea and strategy for surgery.
Healthcare Shares

These 3 ASX healthcare stocks have been crushed in 2026. They could be set for a comeback

CSL is at a 10-year low. Cochlear has fallen 62%. ResMed is down on fears that proved wrong. Are any…

Read more »

A male doctor wearing a white lab coat shrugs his shoulders and holds his hands up in the air looking confused
Healthcare Shares

Should I buy CSL shares in June?

Here's what I expect from the beaten-down biotech stock next month.

Read more »

A man in a business suit holds his hand up to his mouth as though sharing a secret and gives a sly grin.
Healthcare Shares

After CSL's 60% share price crash, insiders are starting to buy

Insiders are buying after a brutal CSL share price fall.

Read more »

A man thinks very carefully about his money and investments.
Healthcare Shares

At under $100 each, Cochlear shares look like a bargain: Here's why

Cochlear Ltd (ASX: COH) shares have now crashed 63% for the year-to-date.

Read more »

A doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

3 ASX 200 shares I'd buy for the future of healthcare

Healthcare investing often requires patience, but I think the sector can produce some excellent long-term winners.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Healthcare Shares

What does a takeover in the US tell us about the value of Telix shares?

Currently there seems to be a steep discount on this stock.

Read more »